INTERNATIONAL PATENT: SHANGHAI MABGEN BIOTECH LTD., 上海迈晋生物医药科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION CONTAINING FAP/4-1BB/CD40 BINDING MOLECULE AND USE THEREOF"

GENEVA, March 16 -- SHANGHAI MABGEN BIOTECH LTD. (Third Floor, No.5 Building, No.18 Jindian Road, Free Trade Pilot Zone,Pudong New Area, Shanghai 201206), 上海迈晋生物医药科技有限公司 (中国上海市浦东新区自由贸易试验区金滇路18号5幢第3层) filed a patent application (PCT/CN2025/118969) for "PHARMACEUTICAL COMPOSITION CONTAINING FAP/4-1BB/CD40 BINDING MOLECULE, AND USE THEREOF" on Sep 04, 2025. With publication no. WO/2026/052000, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent...